Sort
15,273 grants matching “antimicrobial resistance”
The effectiveness of copper surfaces in reducing healthcare acquired infections
$484,392Daniel Zachary Uslan · University Of California Los Angeles · R01 · FY2012 · HS
5500 QTRAP
$484,350John W Turk · Washington University · S10 · FY2010 · RR
Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis
$484,316Chunhao Li · Virginia Commonwealth University · R01 · FY2022 · DE
Functional Polymer Surfaces
$484,000Kenneth J Wynne · Virginia Commonwealth University · · FY2008 · MPS
Mechanism of Action
$483,712David R Andes · University Of Wisconsin-Madison · U19 · FY2014 · AI
Adapting and Implementing Risk-Stratified Penicillin Allergy Evaluation in Key Outpatient Settings
$483,481Cosby A Stone · Vanderbilt University Medical Center · R01 · FY2025 · HS
Clinical Trial of Prophylactic Antibiotics for Children with Vesicoureteral Reflu
$483,476Ron Keren · Children'S Hosp Of Philadelphia · U01 · FY2007 · DK
Preventing Spinal Infection: Ultrasound Triggered Prophylaxis
$483,330Noreen J Hickok · Thomas Jefferson University · R01 · FY2017 · AR
Gallium, a potential new therapeutic for CF airway infections
$483,293Pradeep Singh · University Of Washington · R01 · FY2009 · HL
De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children
$483,212Jason Newland · Washington University · R01 · FY2021 · HS
Defining immunological mechanisms of serovar cross-reactivity to develop broad spectrum protective vaccines for typhoidal and non-typhoidal Salmonella infections in humans
$483,057Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2022 · AI
TANA II
$483,003Thomas M Lietman · University Of California, San Francisco · U10 · FY2013 · EY
Defining the role of single-cell heterogeneity in bacterial vaginosis
$483,000Gina Lewin · Case Western Reserve University · DP2 · FY2024 · AI
Target Antigen Identification to Generate a Cross-serovar Salmonella Vaccine
$483,000Stephen J McSorley · University Of California At Davis · R01 · FY2025 · AI
Topoisomerases and Chromosome Segregation
$482,868Kenneth J Marians · Sloan-Kettering Inst Can Research · R01 · FY2009 · GM
Yersinia Pestis
$482,718Arnold Louie · Ordway Research Institute, Inc. · P01 · FY2008 · AI
Development of HTP Assay for Inhibitors of Aerobactin Production
$482,625Andrew M Gulick · Hauptman-Woodward Medical Research Inst · R01 · FY2016 · AI
Project 1: Genomics of Pathobionts and Transition From Colonization to Infection
$482,586Cesar Augusto Arias · Methodist Hospital Research Institute · P01 · FY2025 · AI
Defining the role of single-cell heterogeneity in bacterial vaginosis
$482,438Gina Lewin · Case Western Reserve University · DP2 · FY2025 · AI
Rat, a regulator of autolysis in S. aureus
$482,291Ambrose L. Cheung · Dartmouth College · R01 · FY2008 · AI
Bacteriophage diversity, dynamics, function, and exploitation
$482,168Graham F. Hatfull · University Of Pittsburgh At Pittsburgh · R35 · FY2025 · GM
Bacteriophage diversity, dynamics, function, and exploitation
$482,168Graham F. Hatfull · University Of Pittsburgh At Pittsburgh · R35 · FY2024 · GM
Understanding and Informing Early Hospital Antibiotic Prescribing for Potential Infection
$482,032Hallie Christine Prescott · University Of Michigan At Ann Arbor · R01 · FY2020 · HS
Precision coordination of therapeutic and prophylactic antibiotics to reduce infection, toxicity, and emergence of resistance following acute abdominal surgery
$482,021Stewart C Wang · University Of Michigan At Ann Arbor · R01 · FY2021 · HS
Chicago Prevention and Intervention Epicenter (Chicago PIE)
$482,006Robert Alan Weinstein · Hektoen Institute For Medical Research · U54 · FY2011 · CK